Expand SPRY Menu
SPRY MENU

SPRY Latest Press Releases

-- August 24, 2026 --

SPRY Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in ARS Pharmaceuticals Inc. Securities Class Action - Contact Levi & Korsinsky Globe Newswire 10:28 AM
Kaplan Fox Encourages ARS Pharmaceuticals Inc. (SPRY) Investors with Losses to Contact the Firm Before October 5, 2026 Newsfile 9:35 AM
Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your Behalf Globe Newswire 8:03 AM

-- August 23, 2026 --

ROSEN, A LEADING LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 8:35 PM

-- August 21, 2026 --

SPRY Investors Have Rights - If You Lost Money Investing in ARS Pharmaceuticals Inc. Contact Robbins LLP for Information Recovering Your Losses Globe Newswire 4:41 PM
Kaplan Fox Alerts Investors of ARS Pharmaceuticals Inc. (SPRY) to a Pending Securities Class Action - Deadline is October 5, 2026 Newsfile 12:15 PM

-- August 20, 2026 --

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 10:23 PM
SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact SueWallSt PRNewswire 1:03 PM

-- August 19, 2026 --

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Globe Newswire 6:41 PM
SPRY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ARS Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky PRNewswire 1:10 PM
Kaplan Fox Notifies ARS Pharmaceuticals Inc. (SPRY) Investors of a Securities Class Action Deadline on October 5, 2026 Newsfile 12:00 PM

-- August 18, 2026 --

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 10:24 PM
SPRY Shareholder Alert: ARS Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm PRNewswire 10:13 AM
SPRY Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in ARS Pharmaceuticals Inc. Securities Class Action - Contact SueWallSt Globe Newswire 10:07 AM
Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your Behalf Globe Newswire 9:09 AM
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and HDFC Bank Limited (HDB) Announced by Holzer & Holzer, LLC Globe Newswire 7:00 AM

-- August 17, 2026 --

Robbins LLP Urges SPRY Stockholders Who Lost Money Investing in ARS Pharmaceuticals Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit PRNewswire 7:11 PM
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ARS Pharmaceuticals and Encourages Investors to Contact the Firm Globe Newswire 5:50 PM
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 12:42 PM
Kaplan Fox Urges Investors of ARS Pharmaceuticals Inc. (SPRY) with Significant Losses to Seek a Leadership Role Before October 5, 2026 Newsfile 11:47 AM
SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact Levi & Korsinsky Globe Newswire 11:24 AM

-- August 16, 2026 --

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit PRNewswire 8:01 PM

-- August 15, 2026 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 11:53 AM

-- August 14, 2026 --

Kaplan Fox Reminds ARS Pharmaceuticals Inc. (SPRY) Investors Seeking Recovery of the Lead Plaintiff Deadline on October 5, 2026 Newsfile 3:31 PM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 11:48 AM
The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - SPRY Globe Newswire 10:19 AM
Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your Behalf Globe Newswire 9:03 AM

-- August 13, 2026 --

ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Globe Newswire 5:05 PM
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results Globe Newswire 4:01 PM
Did You Lose Money Investing in ARS Pharmaceuticals Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against SPRY Newsfile 1:18 PM
SPRY Deadline Alert: SueWallSt Reminds ARS Pharmaceuticals Inc. (SPRY) Investors of Securities Class Action Deadline on October 5, 2026 PRNewswire 12:37 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY PRNewswire 10:01 AM

-- August 12, 2026 --

ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 5:57 PM
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (SPRY) Who Suffered Losses to Contact the Firm Before October 5, 2026 Newsfile 3:00 PM
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and Blaize Holdings, Inc. (BZAI) Announced by Holzer & Holzer, LLC Globe Newswire 11:45 AM
SPRY UPCOMING DEADLINE: Levi & Korsinsky Alerts ARS Pharmaceuticals Inc. Stockholders of Securities Class Action - Contact the Firm PRNewswire 10:07 AM

-- August 11, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY Globe Newswire 5:53 PM
SPRY Investors with Losses in Excess of $100K Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit PRNewswire 5:07 PM
ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 2:18 PM
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm PRNewswire 12:00 PM
SPRY DEADLINE: The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline PRNewswire 11:02 AM
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law Globe Newswire 10:46 AM

-- August 10, 2026 --

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Globe Newswire 6:36 PM
Portnoy Law Firm Announces Class Action on Behalf of ARS Pharmaceuticals, Inc. Investors Globe Newswire 5:32 PM
ROSEN, A LEADING LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY Newsfile 2:13 PM
SPRY DEADLINE: Levi & Korsinsky Reminds ARS Pharmaceuticals Inc. Investors of Upcoming Securities Class Action Deadline Globe Newswire 11:29 AM
SPRY Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ARS Pharmaceuticals Inc. Securities Class Action Globe Newswire 10:34 AM
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY Business Wire 7:30 AM
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY PRNewswire 4:44 AM

-- August 8, 2026 --

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law Business Wire 2:36 PM

-- August 7, 2026 --

Kaplan Fox Notifies ARS Pharmaceuticals Inc. (SPRY) Investors of an Upcoming Lead Plaintiff Deadline on October 5, 2026 Newsfile 6:00 PM
ARS PHARMACEUTICALS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ARS Pharmaceuticals and Encourages Investors to Contact the Firm Globe Newswire 3:20 PM
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm Globe Newswire 12:00 PM
SPRY Deadline Alert: The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. (SPRY) Investors of Securities Class Action Deadline on October 5, 2026 Globe Newswire 10:21 AM
SPRY Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against ARS Pharmaceuticals Inc. PRNewswire 7:21 AM

-- August 6, 2026 --

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit PRNewswire 8:14 PM
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY PRNewswire 6:45 PM
Rosen Law Firm Urges ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Business Wire 5:49 PM
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY) Globe Newswire 3:46 PM
Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (SPRY) Investors to a Securities Class Action Deadline on October 5, 2026 Newsfile 3:45 PM
SPRY DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Globe Newswire 12:13 PM
SPRY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of ARS Pharmaceuticals, Inc. Investors - Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm Globe Newswire 12:06 PM

-- August 5, 2026 --

Shareholder Notice: Robbins LLP Informs Investors of the ARS Pharmaceuticals Inc. Class Action Business Wire 10:24 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of ARS Pharmaceuticals, Inc. Securities and Sets a Lead Plaintiff Deadline of October 5, 2026 Globe Newswire 5:43 PM

-- August 3, 2026 --

ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results Globe Newswire 7:30 AM

-- July 23, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PRNewswire 10:01 AM

-- July 14, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY Globe Newswire 6:22 PM

-- July 9, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY PRNewswire 5:37 PM

-- July 7, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY Globe Newswire 5:38 PM
ARS Pharmaceuticals Announces CEO Succession Globe Newswire 4:30 PM

-- July 6, 2026 --

ARS Pharmaceuticals (SPRY) Securities Fraud Investigation - Levi & Korsinsky PRNewswire 2:00 PM

-- July 1, 2026 --

SPRY Investor Alert: Levi & Korsinsky Investigates ARS Pharmaceuticals (SPRY) for Potential Securities Fraud Business Wire 10:07 AM

-- June 30, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY Globe Newswire 4:45 PM

-- June 29, 2026 --

ARS Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of ARS Pharmaceuticals (SPRY) PRNewswire 1:26 PM

-- June 28, 2026 --

SPRY Investors Have Opportunity to Join ARS Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm Business Wire 11:54 AM

-- June 24, 2026 --

ARS Pharmaceuticals Provides Commercial and Financial Updates Globe Newswire 4:05 PM

-- June 4, 2026 --

Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies Globe Newswire 8:00 AM

-- May 15, 2026 --

ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update Globe Newswire 6:00 AM

-- May 13, 2026 --

ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President Globe Newswire 8:00 AM

-- May 7, 2026 --

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results Globe Newswire 8:00 AM

-- April 15, 2026 --

neffy (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) Globe Newswire 6:05 AM

-- March 27, 2026 --

ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy 1 mg (epinephrine nasal spray) Label Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes